Prelude Therapeutics (PRLD) Research & Development (2019 - 2026)
Prelude Therapeutics (PRLD) reported Research & Development of $16.13 million for Q2 2026, down 37.4% from $25.78 million a year earlier but up 18.6% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Research & Development (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Prelude Therapeutics' Research & Development came in at $69.43 million, down 40.0% year-over-year; for FY2025, it came in at $94.3 million, down 20.1% from FY2024.
- Research & Development has a five-year compound annual growth rate of 14.4% (FY2020 to FY2025).
- By year, Research & Development came in at $118 million in FY2024 (+14.1%), $103.39 million in FY2023 (+11.3%), $92.89 million in FY2022 (+7.0%) and $86.78 million in FY2021 (+80.1%).
- Five-year quarterly Research & Development spans a low of $13.6 million in Q1 2026 and a high of $31.62 million in Q4 2024.
- Year over year, Research & Development has now declined in each of the last five quarters, with an average decline of 18.8% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q4 2021 (growth of 72.8%); the low point was Q1 2026 (a decline of 52.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13.6 million (Q1 2026), $17.99 million (Q4 2025) and $21.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Prelude Therapeutics | 312.03 Mn | -285.27 Mn | - | 16.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.13 Mn |
| Mar 31, 2026 | 13.60 Mn |
| Dec 31, 2025 | 17.99 Mn |
| Sep 30, 2025 | 21.71 Mn |
| Jun 30, 2025 | 25.78 Mn |
| Mar 31, 2025 | 28.82 Mn |
| Dec 31, 2024 | 31.62 Mn |
| Sep 30, 2024 | 29.46 Mn |
| Jun 30, 2024 | 29.51 Mn |
| Mar 31, 2024 | 27.41 Mn |
| Dec 31, 2023 | 30.33 Mn |
| Sep 30, 2023 | 26.26 Mn |
| Jun 30, 2023 | 24.97 Mn |
| Mar 31, 2023 | 21.83 Mn |
| Dec 31, 2022 | 25.87 Mn |
| Sep 30, 2022 | 22.89 Mn |
| Jun 30, 2022 | 21.31 Mn |
| Mar 31, 2022 | 22.82 Mn |
| Dec 31, 2021 | 25.18 Mn |
| Sep 30, 2021 | 22.72 Mn |
API Access
Prelude Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();